303 results match your criteria: "Centre d'evaluation et de traitement de la douleur[Affiliation]"
Eur J Pain
May 2016
Assistance Publique-Hôpitaux de Paris, Therapeutic Research Unit, Department of Internal Medicine, Hôpital Lariboisière, Paris, France.
Background: Despite the development of multimodal analgesia for postoperative pain management, opioids are still required for effective pain relief after knee arthroplasty. We aimed to identify the determinants of post-operative pain intensity and post-operative opioid requirement in this context.
Methods: In this observational prospective study, we recorded patient characteristics, pre-operative pain intensity, anxiety and depression levels, sensitivity and pain thresholds in response to an electrical stimulus, and mu-opioid receptor (OPRM1) and catechol-O-methyltransferase (COMT) single-nucleotide polymorphisms.
Eur J Pain
May 2016
Inserm U-987, Centre d'Evaluation et de Traitement de la Douleur, CHU Ambroise Paré, Assistance Publique Hôpitaux de Paris, Boulogne Billancourt, France.
Background: Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive technique that allows cortical stimulation. Recent studies have shown that rTMS of the primary motor cortex or dorsolateral prefrontal cortex decreases pain in various pain conditions. The aim of this review was to summarize the main characteristics of rTMS-induced analgesic effects and to analyse the current data on its mechanisms of action.
View Article and Find Full Text PDFPresse Med
November 2015
CHU Timone, pôle neurosciences cliniques, centre d'évaluation et de traitement de la douleur, rue Saint-Pierre, 13385 Marseille, France. Electronic address:
The aetiology of cluster headache is partially unknown. Three areas are involved in the pathogenesis of cluster headache: the trigeminal nociceptive pathways, the autonomic system and the hypothalamus. The cluster headache attack involves activation of the trigeminal autonomic reflex.
View Article and Find Full Text PDFPain
November 2015
Division of Population Health Sciences, University of Dundee, Dundee, Scotland, United Kingdom Brain Function Research Group, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa INSERM U-987, Centre d'Evaluation et de Traitement de la Douleur, CHU Ambroise Paré, Assistance Publique Hôpitaux de Paris, Boulogne-Billancourt, France Université Versailles Saint-Quentin, Versailles, France Division of Neurological Pain Research and Therapy, Department of Neurology, Universitätsklinikum Schleswig-Holstein, Kiel, Germany deCODE Genetics/Amgen, Reykjavík, Iceland Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom Academic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom The Alan Edwards Centre for Research on Pain, McGill University, Montreal, Canada Department of Neurology, Beth Israel Deaconess Medical Centre, Harvard Medical School, Boston, USA Zentrum für Anästhesiologie, Intensivmedizin, Schmerztherapie und Palliativmedizin, Benedictus Krankenhaus, Tutzing, Germany Klinik für Anästhesiologie, Technische Universität München, München, Germany Department of Neurosurgery, Helsinki University Central Hospital, Helsinki, Finland Mutual Insurance Company Etera, Helsinki, Finland Department of Clinical Medicine, Danish Pain Research Center, Aarhus University, Aarhus, Denmark Department of Neurology, Aarhus University Hospital, Aarhus, Denmark Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, USA Pain Research, Department of Surgery and Cancer, Faculty of Medicine, Imperial College, Chelsea and Westminster Hospital campus, London, United Kingdom Pain Phenomics and Genomics Lab, University of Toronto Centre for the Study of Pain, University of Toronto, Toronto, Canada Department of Neurology, Technion Faculty of Medicine, Rambam Health Care Campus, Haifa, Israel (O. van Hecke is now with Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom).
For genetic research to contribute more fully to furthering our knowledge of neuropathic pain, we require an agreed, valid, and feasible approach to phenotyping, to allow collaboration and replication in samples of sufficient size. Results from genetic studies on neuropathic pain have been inconsistent and have met with replication difficulties, in part because of differences in phenotypes used for case ascertainment. Because there is no consensus on the nature of these phenotypes, nor on the methods of collecting them, this study aimed to provide guidelines on collecting and reporting phenotypes in cases and controls for genetic studies.
View Article and Find Full Text PDFEur J Pain
March 2016
INSERM U-987 Centre de la Douleur, Hôpital Hotel Dieu, Université Paris Descartes, Paris, France.
Background: To investigate baseline demographics and disease characteristics as predictors of the analgesic effect of duloxetine and pregabalin on diabetic peripheral neuropathic pain (DPNP).
Methods: Based on data from the COMBO-DN study, a multinational clinical trial in DPNP, the potential impact of baseline characteristics on pain relief after 8-week monotherapy with 60 mg/day duloxetine or 300 mg/day pregabalin was assessed using analyses of covariance. Subgroups of interest were characterized regarding their baseline characteristics and efficacy outcomes.
Pain
December 2015
Service d'Anesthésie Réanimation Chirurgicale, Hôpital Raymond Poincaré, AP-HP, Université de Versailles St-Quentin, Garches, France INSERM, U-987, Centre d'Evaluation et de Traitement de la Douleur, Hôpital Ambroise Paré, Université de Versailles St-Quentin, Versailles, France.
Eur J Pain
August 2015
Inserm U-987, Centre d'Evaluation et de Traitement de la Douleur, CHU Ambroise Paré, Assistance Publique Hôpitaux de Paris, Paris, France.
Pain
November 2015
Service d'Anesthésie Réanimation Chirurgicale, Hôpital Raymond-Poincaré, AP-HP, Université de Versailles St-Quentin, Garches, France INSERM U-987, Centre d'Evaluation et de Traitement de la Douleur, Hôpital Ambroise Paré, Boulogne-Billancourt, France; Université Versailles Saint-Quentin, Versailles, France Department of Neurology, University of Würzburg, Würzburg, Germany Service d'orthopédie, Hôpital Raymond-Poincaré, AP-HP, Université de Versailles St-Quentin, Garches, France Service de Biochimie, Hôpital Raymond-Poincaré, Garches, France.
Surgical nerve injury sometimes leads to chronic postsurgical neuropathic pain (CPSNP). The risk factors for this condition are not well understood. We prospectively assessed 46 patients scheduled for iliac crest bone harvest, 2 days (D2) and 3 months (M3) after surgery, to determine the time course of nerve fiber degeneration and expression of the TNF-α and NGF genes in skin punch biopsies.
View Article and Find Full Text PDFPain
November 2015
Division of Neurological Pain Research and Therapy, Department of Neurology, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Germany Department of Neurology, BG University Hospital Bergmannsheil GmbH, Ruhr-University Bochum, Bochum, Germany Department of Pain Medicine, BG University Hospital Bergmannsheil GmbH, Ruhr-University Bochum, Bochum, Germany INSERM U-987, Centre d'Evaluation et de Traitement de la Douleur, CHU Ambroise Paré, Boulogne-Billancourt, France Université Versailles-Saint-Quentin, Versailles, France Department Neurology and Psychiatry, Sapienza University, Roma, Italy Department of Neurology and Danish Pain Research Center, Aarhus University Hospital, Aarhus, Denmark Department of Neurosurgery, Helsinki University Central Hospital, Helsinki, Finland Etera Mutual Pension Insurance Company, Helsinki, Finland Department of Pain Management and Research, Oslo University Hospital, Oslo, Norway Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden Department of Anaesthesiology, Critical Care Medicine, Pain Therapy & Palliative Care, Pain Center Lake Starnberg, Benedictus Hospital, Tutzing, Germany Neuroscience Discovery Research, Eli Lilly and Company, Indianapolis, IN, USA Pain Research, Department of Surgery and Cancer, Imperial College, London, United Kingdom H. Lundbeck A/S, Copenhagen, Denmark Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden Department of Neurology, Odense University Hospital, Odense, Denmark Neuroscience Technologies, Barcelona, Spain Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany Chair of Neurophysiology, Center of Biomedicine and Medical Technology Mannheim CBTM, Medical Faculty Mannheim, Heidelberg University, Germany (T. Mainka is now with the Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany).
Clinical and human experimental pain studies often include so-called "healthy" controls in investigations of sensory abnormalities, using quantitative sensory testing (QST) as an outcome measure. However, the criteria for what is considered "healthy" vary among the different studies and between study centers and investigators, partly explaining the high variability of the results. Therefore, several aspects should be considered during inclusion of healthy volunteers in QST-based trials to have homogenous groups of healthy controls with less variability between human experimental studies, so that results are less likely to be false negative or false positive because of subject-related factors.
View Article and Find Full Text PDFLancet Neurol
July 2015
INSERM U 987 and Centre d'Evaluation et de Traitement de La Douleur, Hôpital Ambroise Paré, Boulogne-Billancourt, France. Electronic address:
Cereb Cortex
June 2016
Central Integration of Pain (NeuroPain) Lab-Lyon Neuroscience Research Center, INSERM U1028, CNRS, UMR5292, Université Claude Bernard, Bron F-69677, France Centre D'évaluation et de Traitement de la Douleur, Hôpital Neurologique, Lyon, France.
While nociceptive cortical activation is now well characterized in humans, understanding of the nociceptive thalamus remains largely fragmentary. We used laser stimuli and intracerebral electrodes in 17 human subjects to record nociceptive-specific field responses in 4 human thalamic nuclei and a number of cortical areas. Three nuclei known to receive spinothalamic (STT) projections in primates (ventro-postero-lateral [VPL], anterior pulvinar [PuA], and central lateral [CL]) exhibited responses with similar latency, indicating their parallel activation by nociceptive afferents.
View Article and Find Full Text PDFEur J Pain
January 2016
INSERM U987, Centre d'Evaluation et de Traitement de la Douleur, Hôpital Ambroise Paré, Boulogne-Billancourt, France.
Background: Experimental and clinical observations of interactions between the nociceptive and thermoceptive systems have suggested that they could be part of the homoeostatic system relating to the condition of the body, described as 'interoception'. Homoeostatic physiological systems are extensively interconnected. Thus, consistent with this hypothesis, we would expect thermoregulatory challenges to be associated with changes in pain perception.
View Article and Find Full Text PDFTherapie
August 2015
Hospices Civils de Lyon, Délégation à la Recherche Clinique et à l'Innovation, Cellule Innovation/UMR-CNRS 5510/MATEIS, Lyon, France.
Introduction: The capsaïcine 8% cutaneous patch (Qutenza®) was recently approved for the management of patients with peripheral neuropathic pain (PNP). Considering its limited clinical efficacy data, its improvement of medical benefit was determined to be 5 which was insufficient to support its reimbursement in addition to diagnosis related groups'tarifs. Nevertheless its commercialization was associated with a marked interest considering the unmet therapeutic needs for patients with PNP.
View Article and Find Full Text PDFHeadache
June 2015
Centre d'Evaluation et de Traitement de la Douleur, Hôpital Timone, Marseille, France.
Objective: The etiology of transient global amnesia (TGA) remains unclear, and flow disturbances in the mesial temporal lobes secondary to venous congestion have been proposed as a potential cause. The occurrence of TGA during a migraine attack is a rare condition.
Methods: This 11-year retrospective study in one French center describes patients' characteristics, type of migraine, investigations, treatment with vasoconstrictor during the TGA/migraine attack, and outcome in patients who had TGA during a migraine attack.
Pain
April 2015
INSERM U-987, Centre d'Evaluation et de Traitement de la Douleur, CHU Ambroise Paré, APHP, F-92100 Boulogne-Billancourt, France and Université Versailles Saint-Quentin, Versailles, F-78035, France.
Neuropathic pain (NP) is a significant medical and socioeconomic burden. Epidemiological surveys have indicated that many patients with NP do not receive appropriate treatment for their pain. A number of pharmacological agents have been found to be effective in NP on the basis of randomized controlled trials including, in particular, tricyclic antidepressants, serotonin and norepinephrine reuptake inhibitor antidepressants, pregabalin, gabapentin, opioids, lidocaine patches, and capsaicin high-concentration patches.
View Article and Find Full Text PDFEur J Pain
November 2015
Institut des Neurosciences Cellulaires et Intégratives, Centre National de la Recherche Scientifique, France.
Background: Pre-clinical research has shown β2 -adrenoceptors to be essential for the antiallodynic action of antidepressant drugs in murine models of neuropathic pain and that sustained treatment with β2 -agonists has an antiallodynic action. Here, we clinically investigated whether chronic β2 -agonist treatments may influence the incidence of post-thoracotomy chronic pain, defined as pain that recurs or persists along a thoracotomy scar more than 2 months after surgery, either neuropathic or non-neuropathic.
Methods: We conducted an epidemiological study on patients operated by thoracotomy.
Gynecol Obstet Fertil
March 2015
Service de gynécologie endocrinienne et médecine de la reproduction, hôpital Jeanne-de-Flandre, CHRU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France; Service de gynécologie médicale, orthogénie et médecine du couple, hôpital Jeanne-de-Flandre, CHRU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France. Electronic address:
Migraine is a common pathology in women. Migraine disease is well defined by the International Headache Society and has to be distinguished from others types of headaches. The occurrence of migraine attacks is frequently linked to the menstrual cycle.
View Article and Find Full Text PDFCephalalgia
November 2015
Aix Marseille Université, CNRS 7289 - Institut de Neurosciences Timone, Centre d'Evaluation et d'Information sur la Pharmacodépendance & Addictovigilance PACA-Corse, Service de Pharmacologie Clinique et Pharmacovigilance, France
Introduction: The objective of this study was to estimate and to characterize the actual patterns of triptan use and overuse in France using a drug reimbursement database.
Methods: We included all people covered by the French General Health Insurance System (GHIS) from the Provence-Alpes-Côte-d'Azur (PACA) and Corsica administrative areas who had at least one dispensed dose of triptans between May 2010 and December 2011. All dispensed doses of triptans, migraine prophylactic treatment and psychotropic medications were extracted from the GHIS database.
Contemp Clin Trials
March 2015
Clermont Université, Laboratoire de Pharmacologie, Faculté de médecine, F-63001 Clermont-Ferrand, France; Inserm, CIC 1405, UMR Neurodol 1107, F-63003 Clermont-Ferrand, France; CHU Clermont-Ferrand, Centre de Pharmacologie Clinique, F-63003 Clermont-Ferrand, France. Electronic address:
Background: Anti-cancer chemotherapy often induces peripheral neuropathy and consequent cognitive and quality of life impairment. Guidelines recommend antiepileptics or antidepressants but their efficacy is limited.Dextromethorphan, a N-methyl-D-aspartate receptor antagonist, has shown its efficacy in painful diabetic neuropathy and in post-operative pain but has not been studied in chemotherapy-induced peripheral neuropathy.
View Article and Find Full Text PDFLancet Neurol
February 2015
Division of Pain Medicine, Department of Anesthesiology, UCSD, San Diego, CA, USA.
Background: New drug treatments, clinical trials, and standards of quality for assessment of evidence justify an update of evidence-based recommendations for the pharmacological treatment of neuropathic pain. Using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE), we revised the Special Interest Group on Neuropathic Pain (NeuPSIG) recommendations for the pharmacotherapy of neuropathic pain based on the results of a systematic review and meta-analysis.
Methods: Between April, 2013, and January, 2014, NeuPSIG of the International Association for the Study of Pain did a systematic review and meta-analysis of randomised, double-blind studies of oral and topical pharmacotherapy for neuropathic pain, including studies published in peer-reviewed journals since January, 1966, and unpublished trials retrieved from ClinicalTrials.
Br J Anaesth
March 2015
Service d'anesthésie, Hôpital Raymond Poincaré, Assistance Publique Hôpitaux de Paris, F-92380 Garches, France INSERM, U-987, Hôpital Ambroise Paré, Centre d'Evaluation et de Traitement de la Douleur, F-92100, France Université Versailles Saint-Quentin, F-78035 Versailles, France.
The role for tramadol in multimodal postsurgical analgesic strategies remains unclear. We undertook a systematic review to evaluate the utility of combining tramadol with morphine after surgery. We searched the MEDLINE, EMBASE, LILAC, Cochrane, and Clinical Trial Register databases for randomized, controlled studies comparing tramadol with placebo or active control in patients undergoing surgery.
View Article and Find Full Text PDFEur J Anaesthesiol
April 2015
From the Service d'Anesthésie Réanimation Chirurgicale, Hôpital Raymond Poincaré, Assistance Publique Hôpitaux de Paris, Garches (NH, DF,VM), INSERM, U-987, Hôpital Ambroise Paré, Centre d'Evaluation et de Traitement de la Douleur, Boulogne Billancourt (DF,FP-J,VM), and Université Versailles Saint-Quentin, Versailles, France (DF).
Background: Chronic pain and opioid consumption may trigger diffuse hyperalgesia, but their relative contributions to pain vulnerability remain unclear.
Objectives: To assess preoperative opioid-induced hyperalgesia and its postoperative clinical consequences in patients with chronic pain scheduled for orthopaedic surgery.
Design: A prospective observational study.
Brain Stimul
May 2015
INSERM U-987, Centre d'Evaluation et de Traitement de la Douleur, CHU Ambroise Paré, Assistance Publique Hôpitaux de Paris, F-92100 Boulogne Billancourt, France; Université Versailles-Saint-Quentin, Versailles F-78035, France.
Background: Repetitive transcranial magnetic stimulation (rTMS) of the primary motor cortex (M1) at high frequency (>5 Hz) induces analgesic effects, probably by activating pain modulation systems. A new rTMS paradigm--theta burst stimulation (TBS)--consists of bursts of three pulses at 50 Hz repeated five times per second. Like high frequency rTMS, both intermittent and prolonged continuous TBS (iTBS and pcTBS) lead to a facilitation of cortical excitability.
View Article and Find Full Text PDFPain
December 2014
Inserm U-987, Centre d'Evaluation et de Traitement de la Douleur, CHU Ambroise Paré, Assistance Publique Hôpitaux de Paris, Boulogne-Billancourt, France Université Versailles-Saint-Quentin, Versailles, France.
The simultaneous application of innocuous cutaneous warm and cold stimuli with a thermal grill can induce both paradoxical pain and paradoxical warmth (heat). The goal of this study was to investigate further the relationships between these paradoxical sensations. Stimuli were applied to the palms of the right hands of 21 volunteers with a thermode consisting of 6 bars, the temperature of which was controlled by Peltier elements.
View Article and Find Full Text PDFPain
October 2014
Neurologische Klinik und Poliklinik, Technische Universität, München, Germany.
Sensory profiles are heterogeneous in neuropathic pain disorders, and subgroups of patients respond differently to treatment. To further explore this, patients in the COMBO-DN study were prospectively assessed by the Neuropathic Pain Symptom Inventory (NPSI) at baseline, after initial 8-week therapy with either duloxetine or pregabalin, and after subsequent 8-week combination/high-dose therapy. Exploratory post hoc cluster analyses were performed to identify and characterize potential subgroups through their scores in the NPSI items.
View Article and Find Full Text PDF